Facile Synthesis of Thalidomide

被引：11

作者：

Binh Duong Vu ^{[1
]}

Ngoc Minh Ho Ba ^{[1
]}

Dinh Chau Phan ^{[2
]}

机构：

[1] Vietnam Mil Med Univ, R&D Drug Ctr, Phuc La Ward, 160 Phung Hung Str, Hanoi 10000, Vietnam

[2] Hanoi Univ Sci & Technol, Sch Chem Engn, Bach Khoa Ward, 1 Dai Co Viet Str, Hanoi 10000, Vietnam

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2019年 / 23卷 / 07期

关键词：

thalidomide; N-phthaloyl-DL-glutamic anhydride; leprosy; rheumatoid arthritis; neoplastic diseases; multiple myeloma; EFFICIENT; ANALOGS;

D O I：

10.1021/acs.oprd.9b00122

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

We report a simple and facile procedure for the preparation of thalidomide in two steps with a high overall yield (56%). The preparation was composed of a reaction between anhydride phthalic and L-glutamic acid to form N-phthaloyl-DL-glutamic acid (IV), and a cyclization step using IV reacted with ammonium acetate in diphenyl ether to create thalidomide. Reaction parameters reaction time, temperature, solvent, and molar ratio of reagents in the procedure are optimized so that the reaction performance is highest while ensuring environmental friendliness. Moreover, this process has great potential for the industrial scale of thalidomide. These compounds were identified through IR, MS, H-1 NMR, and C-13 NMR.

引用

页码：1374 / 1377

页数：4

共 50 条

[21] Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina
Santucci, C.
Papale, R.
Perez, A.
Cardoso, B.
Bignone, K.
[J]. DRUG SAFETY, 2008, 31 (10) : 947 - 947
[22] Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina
C. Santucci
R. Papale
A. Perez
B. Cardoso
I. Bignone
[J]. Drug Safety, 2008, 31 : 885 - 885
[23] Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions
Yamasaki, Paulo Renato
do Nascimento, Dejair Caetano
Chelucci, Rafael Consolin
Fernandes Belone, Andrea de Faria
Rosa, Patricia Sammarco
Diorio, Suzana Madeira
Ferreira de Melo, Thais Regina
Barbieri, Karina Pereira
Polesi Placeres, Marisa Campos
Carlos, Iracilda Zepone
Chung, Man Chin
dos Santos, Jean Leandro
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3084 - 3087
[24] Thalidomide in multiple myeloma
García-Sanz, R
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (02) : 195 - 213
[25] Thalidomide: An antineoplastic agent
Amato R.J.
[J]. Current Oncology Reports, 2002, 4 (1) : 56 - 62
[26] Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma
Offidani, M
Corvatta, L
Marconi, M
Olivieri, A
Catarini, M
Mele, A
Brunori, M
Candela, M
Malerba, L
Capelli, D
Montanari, M
Leoni, P
[J]. HEMATOLOGY JOURNAL, 2004, 5 (04) : 312 - 317
[27] A facile synthesis of unsymmetrical ureas
Bogolubsky, Andrey V.
Ryabukhin, Sergey V.
Pipko, Sergey E.
Lukin, Oleg
Shivanyuk, Alexander
Mykytenko, Dmytro
Tolmachev, Andrey
[J]. TETRAHEDRON, 2011, 67 (20) : 3619 - 3623
[28] Thalidomide maintenance therapy for patients with multiple myeloma: Meta-analysis
Kagoya, Yuki
Nannya, Yasuhito
Kurokawa, Mineo
[J]. LEUKEMIA RESEARCH, 2012, 36 (08) : 1016 - 1021
[29] Thalidomide for patients with recurrent lymphoma
Pro, B
Younes, A
Albitar, M
Dang, NH
Samaniego, F
Romaguera, J
McLaughlin, P
Hagemeister, FB
Rodriguez, MA
Clemons, M
Cabanillas, F
[J]. CANCER, 2004, 100 (06) : 1186 - 1189
[30] Synthesis of Hydroxylactams and Esters Derived from Thalidomide and Their Antitumor Activities
Sun, Guanglong
Liu, Xiangchao
Zhou, Heng
Liu, Zenglu
Mao, Zhenmin
[J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2014, 35 (05): : 1337 - 1342

← 1 2 3 4 5 →